Yahoo Web Search

Search results

1. • 

     Merck scraps Keytruda trial for prostate cancer after dismal interim data

     Reuters via Yahoo News· 1 year ago

     The interim analysis showed the therapy did not extend survival or help extend the time a patient...

2. • 

     Merck scraps third prostate cancer study as Keytruda therapy disappoints

     Reuters via Yahoo News· 1 year ago

     Merck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...

3. • 

     Immunotherapy for Cancer: What Are My Options?

     Verywell Health via Yahoo News· 8 months ago

     Immunotherapy is a relatively new approach to cancer treatment. It improves the body's immune system's ability to find and fight cancer. Since 2010,...

4. • 

     Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask

     Fortune via Yahoo Finance· 1 year ago

     Cancer vaccines—it’s a concept seemingly torn from the plot of a futuristic sci-fi movie, or from...

5. • 

     The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech...

     Investor's Business Daily· 1 year ago

     Startling cancer vaccine results from Moderna could drive the company's second act and usher in the...

6. • 

     U.S. FDA panel to review expanded use of Merck-AstraZeneca's cancer drug

     Reuters via Yahoo News· 1 year ago

     The U.S. Food and Drug Administration's (FDA) committee is scheduled to meet on April 28. The...

7. • 

     Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J

     Zacks via Yahoo Finance· 4 months ago

     Ambrx Biopharma AMAM signed a definitive agreement with Johnson & Johnson JNJ. Per the agreement...

8. • Q2 2023 PDS Biotechnology Corp Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 9 months ago

     Participants Frank K. Bedu-Addo; President, CEO & Director; PDS Biotechnology Corporation Lauren V. Wood; Chief Medical Officer; PDS Biotechnology Corporation Matthew C. Hill; CFO, Principal ...

9. • Merck's Keytruda Combo Therapy Less Effective Than Chemo In Lung Cancer Patients, Data Shows

     Benzinga via Yahoo Finance· 1 year ago

     https://cdn.benzinga.com/files/images/story/2023/03/17/mrk.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Merck & Co Inc's (NYSE: MRK) MK-7684A failed the open-label portion of a Phase ...

10. • 

      15 Deadliest Cancers in the U.S.

      Insider Monkey via Yahoo Finance· 10 months ago

      In this article, we will discuss the 15 deadliest cancers in the U.S. To skip our detailed analysis and recent updates regarding cancer research and the...